|
|
Volumn 8, Issue 4, 2009, Pages 259-
|
|
Past the wall in cardiovascular R&D
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARDIOVASCULAR AGENT;
CLOPIDOGREL;
CYTOCHROME P450 2C19;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRASUGREL;
PURINERGIC P2Y12 RECEPTOR;
TORCETRAPIB;
ARTERY THROMBOSIS;
CARDIOVASCULAR DISEASE;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DRUG APPROVAL;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG METABOLISM;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
UNSPECIFIED SIDE EFFECT;
ANIMALS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
HUMANS;
RESEARCH;
|
|
EID: 64049113379
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2853 Document Type: Editorial |
|
Times cited : (9)
|
|
References (0)
|
